Publication:
European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients.

dc.contributor.authorNyssen, Olga P
dc.contributor.authorBordin, Dmitry
dc.contributor.authorTepes, Bojan
dc.contributor.authorPérez-Aisa, Ángeles
dc.contributor.authorVaira, Dino
dc.contributor.authorCaldas, Maria
dc.contributor.authorBujanda, Luis
dc.contributor.authorCastro-Fernandez, Manuel
dc.contributor.authorLerang, Frode
dc.contributor.authorLeja, Marcis
dc.contributor.authorRodrigo, Luís
dc.contributor.authorRokkas, Theodore
dc.contributor.authorKupcinskas, Limas
dc.contributor.authorPérez-Lasala, Jorge
dc.contributor.authorJonaitis, Laimas
dc.contributor.authorShvets, Oleg
dc.contributor.authorGasbarrini, Antonio
dc.contributor.authorSimsek, Halis
dc.contributor.authorAxon, Anthony T R
dc.contributor.authorBuzás, György
dc.contributor.authorMachado, Jose Carlos
dc.contributor.authorNiv, Yaron
dc.contributor.authorBoyanova, Lyudmila
dc.contributor.authorGoldis, Adrian
dc.contributor.authorLamy, Vincent
dc.contributor.authorTonkic, Ante
dc.contributor.authorPrzytulski, Krzysztof
dc.contributor.authorBeglinger, Christoph
dc.contributor.authorVenerito, Marino
dc.contributor.authorBytzer, Peter
dc.contributor.authorCapelle, Lisette
dc.contributor.authorMilosavljević, Tomica
dc.contributor.authorMilivojevic, Vladimir
dc.contributor.authorVeijola, Lea
dc.contributor.authorMolina-Infante, Javier
dc.contributor.authorVologzhanina, Liudmila
dc.contributor.authorFadeenko, Galina
dc.contributor.authorAriño, Ines
dc.contributor.authorFiorini, Giulia
dc.contributor.authorGarre, Ana
dc.contributor.authorGarrido, Jesús
dc.contributor.authorF Pérez, Cristina
dc.contributor.authorPuig, Ignasi
dc.contributor.authorHeluwaert, Frederic
dc.contributor.authorMegraud, Francis
dc.contributor.authorO'Morain, Colm
dc.contributor.authorGisbert, Javier P
dc.contributor.authorHp-EuReg Investigators
dc.date.accessioned2023-02-09T09:41:21Z
dc.date.available2023-02-09T09:41:21Z
dc.date.issued2020-09-21
dc.description.abstractThe best approach for Helicobacter pylori management remains unclear. An audit process is essential to ensure clinical practice is aligned with best standards of care. International multicentre prospective non-interventional registry starting in 2013 aimed to evaluate the decisions and outcomes in H. pylori management by European gastroenterologists. Patients were registered in an e-CRF by AEG-REDCap. Variables included demographics, previous eradication attempts, prescribed treatment, adverse events and outcomes. Data monitoring was performed to ensure data quality. Time-trend and geographical analyses were performed. 30 394 patients from 27 European countries were evaluated and 21 533 (78%) first-line empirical H. pylori treatments were included for analysis. Pretreatment resistance rates were 23% to clarithromycin, 32% to metronidazole and 13% to both. Triple therapy with amoxicillin and clarithromycin was most commonly prescribed (39%), achieving 81.5% modified intention-to-treat eradication rate. Over 90% eradication was obtained only with 10-day bismuth quadruple or 14-day concomitant treatments. Longer treatment duration, higher acid inhibition and compliance were associated with higher eradication rates. Time-trend analysis showed a region-dependent shift in prescriptions including abandoning triple therapies, using higher acid-inhibition and longer treatments, which was associated with an overall effectiveness increase (84%-90%). Management of H. pylori infection by European gastroenterologists is heterogeneous, suboptimal and discrepant with current recommendations. Only quadruple therapies lasting at least 10 days are able to achieve over 90% eradication rates. European recommendations are being slowly and heterogeneously incorporated into routine clinical practice, which was associated with a corresponding increase in effectiveness.
dc.identifier.doi10.1136/gutjnl-2020-321372
dc.identifier.essn1468-3288
dc.identifier.pmid32958544
dc.identifier.unpaywallURLhttps://gut.bmj.com/content/gutjnl/70/1/40.full.pdf
dc.identifier.urihttp://hdl.handle.net/10668/16292
dc.issue.number1
dc.journal.titleGut
dc.journal.titleabbreviationGut
dc.language.isoen
dc.organizationHospital Costa del Sol
dc.organizationÁrea de Gestión Sanitaria Sur de Sevilla
dc.organizationAGS - Sur de Sevilla
dc.page.number40-54
dc.pubmedtypeJournal Article
dc.pubmedtypeMulticenter Study
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rights.accessRightsopen access
dc.subjecthelicobacter pylori
dc.subjecthelicobacter pylori - treatment
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAnti-Bacterial Agents
dc.subject.meshDrug Therapy, Combination
dc.subject.meshEurope
dc.subject.meshFemale
dc.subject.meshHelicobacter Infections
dc.subject.meshHelicobacter pylori
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshPractice Patterns, Physicians'
dc.subject.meshProspective Studies
dc.subject.meshProton Pump Inhibitors
dc.subject.meshRegistries
dc.titleEuropean Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number70
dspace.entity.typePublication

Files